TOI
Oncology Institute, Inc.
Latest Form 4:Purchase$95KbyChernett Jorey (10% Owner) · filed Jul 22, 2026
Oncology Institute, Inc. (TOI) has 53 SEC Form 4 filings (75 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Jul 29, 2026.
The most active filer is 10% Owner Chernett Jorey with 14 filings. Insiders have net bought $2.0M over the trailing 6 months.
- Industry:Medical - Care Facilities
- CEO:Daniel Virnich
- Employees:641
- HQ:Cerritos, CA, US
- IPO:2020-06-04
Insider Buying
$2.6M
reported purchases (SEC code P)
Insider Selling
$21.6M
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Market Cap
$631.9M
Price slightly stale
| Source | ||||||
|---|---|---|---|---|---|---|
| 10% Owner | Purchase | 18,000 | $95K | Jul 22 | SEC ↗ | |
| Chief Medical Officer | Sale | 23,452 | $150K | Jul 17 | SEC ↗ | |
| 10% Owner | Purchase | 15,000 | $88K | Jul 13 | SEC ↗ | |
| 10% Owner | Purchase | 18,000 | $90K | Jun 24 | SEC ↗ | |
Podnos YaleFirst filing | Chief Medical Officer | Sale | 23,451 | $126K | Jun 9 | SEC ↗ |
| 10% Owner | Purchase | 12,000 | $57K | Jun 5 | SEC ↗ | |
| 10% Owner | Purchase | 35,000 | $143K | May 21 | SEC ↗ | |
| 10% Owner | Purchase | 33,500 | $136K | May 21 | SEC ↗ | |
Kaushal MohitFirst filing | Director | Sale | 57,286 | $201K | Apr 16 | SEC ↗ |
Kaushal MohitFirst filing | Director | Sale | 38,433 | $135K | Apr 16 | SEC ↗ |
| 10% Owner | Purchase | 20,000 | $62K | Apr 13 | SEC ↗ | |
| 10% Owner | Purchase | 27,429 | $81K | Mar 30 | SEC ↗ | |
| 10% Owner | Purchase | 50,000 | $158K | Mar 27 | SEC ↗ | |
| 10% Owner | Purchase | 125,000 | $389K | Mar 25 | SEC ↗ | |
| 10% Owner | Purchase | 25,000 | $84K | Mar 23 | SEC ↗ | |
| 10% Owner | Purchase | 263,000 | $768K | Mar 17 | SEC ↗ | |
| 10% Owner | Purchase | 60,985 | $201K | Mar 17 | SEC ↗ | |
| 10% Owner | Purchase | 75,000 | $257K | Mar 17 | SEC ↗ | |
Carter Robert RossFirst filing | Chief Financial Officer | Sale | 247 | $879 | Jan 5 | SEC ↗ |
Hively BradFirst filing | Director | Sale | 13,333 | $50K | Dec 16 | SEC ↗ |
Pacala Mark LFirst filing | Director | Sale | 50,000 | $200K | Nov 20 | SEC ↗ |
M33 Growth I L.P.First filing | Director, 10% Owner | Sale | 6,700,000 | $20.7M | Sep 5 | SEC ↗ |
Related companies
Oncology Institute, Inc. is in the Healthcare sector.